Related Experiment Video
Updated: Jun 12, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Atomic Ga Site Enables Photonanozymes with Specific Inhibition Modes for Primary Drug Screening
Jian Li1, Yu Wu1, Wenxuan Jiang1
1State Key Laboratory of Green Pesticide, International Joint Research Center for Intelligent Biosensing Technology and Health, College of Chemistry, Central China Normal University, Wuhan 430079, P.R. China.
Abstract:
Enzyme inhibition plays a crucial role in drug discovery by governing interactions between molecules and distinct enzymatic sites, facilitating the identification of early drug candidates. However, most nanozymes have been limited to single active site inhibition models, leaving gaps in understanding inhibitor interactions and their dynamic modulation by external stimuli. Hence, an in-depth understanding of nanozyme inhibition across different functional domains, particularly under external stimuli like light irradiation, remains challenging. Herein, we report a carbon nitride photonanozyme with atomically dispersed Ga-N3-coupled cyano sites (Ga-CN) for analyzing and screening antithyroid drugs via photoregulated inhibition modes. Ga sites modulate the electronic structure of cyano sites, enhancing photoinduced charge separation and synergistically boosting peroxidase-like activity. Inhibition kinetics reveal that thiol-containing drugs exhibit distinct mixed inhibition modes by targeting different active sites, with inhibition markedly enhanced under light. Leveraging these differential inhibition patterns, we developed a Ga-CN-based sensor array, integrating machine learning for precise antithyroid drug screening, facilitating early drug discovery.

